Associated British Foods PLC
1 November 1999
ABF Adds Enzymes to Growing Ingredients Portfolio
In a move aimed at progressing Associated British Foods' (ABF) growth in the
international food ingredients sector, ABF has today (1 November) acquired
Rohm Enzyme GmbH from Degussa-Huls GmbH of Germany.
Rohm Enzyme is one of the world's leading enzyme producers in the food sector,
and is strong in the bakery ingredients market. It also supplies enzymes for
the industrial and animal feed markets.
Commenting on the acquisition, Peter Jackson, Chief Executive of ABF, said,
'Rohm Enzymes is a technically advanced business which will provide an
excellent fit with ABF's other food ingredient businesses. The combination of
enzymes with our existing operations will allow the Company to substantially
improve its product offering and enhance its geographical spread in a sector
where we see considerable potential for growth.'
ABF's new subsidiary has its headquarters in Darmstadt, Germany, with
production and industrial enzyme facilities in Rajamaki, Finland. Rohm Enzyme
is expected to generate revenues approaching DM 50 million this year from its
sales spread throughout Europe, North America and Asia.
The Company will be managed through ABF's fast growing ABITEC subsidiary,
which manufactures and markets a range of complementary ingredients and has
particular strengths as a supplier to the bakery sectors of Europe and North
America.
Enquiries to:
John Bason, Finance Director - 020-7589 6363
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.